NCT03107806View on ClinicalTrials.gov

Monitoring Glucose Levels in Patients With Myocardial Infarction

NATerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Acute Coronary SyndromesHyperglycemiaHypoglycemia
Interventions
DEVICE

OptiScanner®

"1. Glucose monitoring by OptiScanner® for 48 h~2. Glucose lowering intervention (insulin) guided by OptiScanner®"

Trial Locations (1)

17176

Karolinska University hospital, Stockholm

Sponsors

Lead Sponsor

Lars Ryden
All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

collaborator

Swedish Heart Lung Foundation

OTHER

lead

Lars Ryden

OTHER